STAFFORDSHIRE-based veterinary products supplier Dechra Pharmaceuticals has experienced a surge in revenues across its divisions.

In a trading statement ahead of the publication of its preliminary results for the year ended June 30, Dechra revealed group revenue was approximately 9.3% ahead of the equivalent period last year.

Excluding the impact of Eurovet Animal Health  - the Dutch drugs firm Dechra bought for £113m in May – group revenue was 7.5% ahead of last year.

Revenue was up 16% in i......for the full story register now for free or login below...